tiprankstipranks
Trending News
More News >
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
US Market

Legend Biotech (LEGN) Income Statement

Compare
607 Followers

Legend Biotech Income Statement

Last quarter (Q3 2025), Legend Biotech's total revenue was $272.33M, an increase of 69.99% from the same quarter last year. In Q3, Legend Biotech's net income was $-39.69M. See Legend Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 627.24M$ 285.14M$ 117.00M$ 68.83M$ 75.00M
Gross Profit
$ 392.66M$ 140.93M$ 51.64M$ 68.83M$ 75.00M
Operating Expenses
$ 695.90M$ 580.41M$ 507.26M$ 461.11M$ 75.00M
Depreciation and Amortization
$ 23.36M$ 20.45M$ 18.39M$ 13.92M$ 9.93M
EBITDA
$ -113.16M$ -477.87M$ -416.54M$ -392.38M$ -298.16M
Operating Income
$ -303.24M$ -439.49M$ -455.62M$ -392.29M$ 0.00
Other Income/Expenses
$ 145.11M$ -80.63M$ 9.90M$ -14.91M$ -308.29M
Pretax Income
$ -158.13M$ -520.12M$ -445.72M$ -407.20M$ -308.29M
Net Income
$ -177.03M$ -518.25M$ -446.35M$ -403.58M$ -266.37M
Per Share Metrics
Basic EPS
$ -1.94$ -5.88$ -5.62$ -5.48$ -5.14
Diluted EPS
$ -1.94$ -5.88$ -5.62$ -5.48$ -5.14
Weighted Average Shares Outstanding
91.43M 88.04M 79.52M 70.43M 59.08M
Weighted Average Shares Outstanding (Diluted)
91.43M 88.04M 79.52M 70.43M 59.08M
Currency in USD

Legend Biotech Earnings and Revenue History